Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Cited by (324)

Items 301–324 of 324

1. Cell-Free DNA Utility and Value of Recommendation
   Benjamin Philip Levy · 2018 · Archives of Pathology & Laboratory Medicine
2. Response to osimertinib in EGF816-resistant T790M-mutated lung cancer
   James Chun-Yen Kuo, Natasha B. Leighl · 2018 · Journal of Current Oncology
3. Liquid biopsy when MEAT is not the treat
   K Govind Babu · 2019 · Indian Journal of Medical and Paediatric Oncology
4. Case Studies: Molecular Pathology Perspective and Impact on Oncologic Patients’ Management
   Mireia Castillo-Martín, Joana Mourato Ribeiro · 2019 · Learning materials in biosciences
5. Análise de custo-efetividade do painel de sequenciamento de nova geração do DNA circulante tumoral no diagnóstico dos pacientes com câncer de pulmão de não pequenas células não escamoso metastático
   Luiz Henrique Araujo, Renata A. Coudry, Clarissa Serodio da Rocha Baldotto, Mariana Sebastião, M D'Innocenzo, Micha Nussbaum, Rodrigo Shimabukuro Ho · 2019 · Jornal Brasileiro de Economia da Saúde
6. Update on Lung Cancer and Treatment Strategies
   Gul Shehnaz, Akhtar Muhammad, Abdullah, Muhammad Ilyas · 2016
7. Liquid Biopsy: A New, Non-Invasive Early Diagnostic and Prognostic Tool in Oncology
   Ciro Comparetto, Franco Borruto · 2020 · Journal of cancer research updates
8. Liquid Biopsies: New Technology and Evidence
   Daniel Morgensztern · 2021 · Current cancer research
9. Longing for Endor: Little People and the Ideological Colonization of the European Fantasy Genre
   Catriona McAra · 2012 · University of Huddersfield Repository (University of Huddersfield)
10. The Role of the Gut Microbiome in Neuromodulation Therapies as a Potential Treatment Adjunct for Multiple Sclerosis
    Piper Tonne, Deondre Do, Nabeeha Hasan, Sravya Gundapaneni, Ariya Reddy, Saadhana Sridharan, Sierra Richardson · 2021 · Berkeley Pharma Tech Journal of Medicine
11. Liquid Biopsy as an Option for Predictive Testing and Prognosis in Patients with Lung Cancer
    Alvida Qvick, Bianca Stenmark, Jessica Carlsson, Johan Isaksson, Christina Karlsson, Gisela Helenius · 2021 · Research Square
12. Changing the landscape of non-small cell lung cancer disparities
    Joab Otieno Odera, Muthana Al Abo, Steven R. Patierno, Jeffrey Melson Clarke, Jennifer A. Freedman · 2021 · Journal of Cancer Biology
13. New insights of liquid biopsy in ovarian cancer
    Antoniadis Panagiotis, Gheorghe Florentina Alina, Nitu Madalina Ana Maria, Nitu Cezara Gabriela, Diana Constantinescu, Florentina Duică · 2022 · Journal of Genetic Medicine and Gene Therapy
14. Data from A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study
    Han Si, Michael A. Kuziora, Katie Quinn, Elena Helman, Jiabu Ye, Feng Liu, Urban J. Scheuring, Solange Peters, Naiyer A. Rizvi, Philip Z. Brohawn et al. · 2023
15. Data from A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study
    Han Si, Michael A. Kuziora, Katie Quinn, Elena Helman, Jiabu Ye, Feng Liu, Urban J. Scheuring, Solange Peters, Naiyer A. Rizvi, Philip Z. Brohawn et al. · 2023
16. Precision medicine-based cancer care
    Stephanie Santos, Eddy Shih-Hsin Yang · 2023 · Elsevier eBooks
17. Concordance of genomic mutations between tissue and ctDNA in non-small cell lung cancer: impact of time interval stratified by stage, smoking history and treatment
    Kun Li, Nana Zhang, Bing Xu, Zichen Liu, Dan Zhao, Yujie Dong, Jing Mu, Haifeng Lin, Guangyu Shan, Sihang Gao et al. · 2023 · Research Square
18. Highly consistency of PIK3CA mutation spectrum between circulating tumor DNA and paired tissue in lung cancer patients
    Yan Liu, Hui Li, Xiang Li, Ting-Ting Zhang, Yang Zhang, Jing Fei Zhu, Heran Cui, Rixin Li, Ying Cheng · 2024 · Heliyon
19. Comprehensive genetic profiling using tissue and blood in locally advanced tumors
    Kenji Fujiyoshi, Rie Sugihara, Naoki Miyamoto, Yoriko Watanabe, Tomoya Sudo, Sanae Numata, Jun Akiba, Hideyuki Abe, Yuka Ichinose, Kenji Inoue et al. · 2025 · Oncology Reports
20. Diagnostic accuracy of circulating tumor DNA for detection of ALK rearrangement in lung cancer: A systematic review and meta-analysis of 14 studies
    Jiantong Sun, Lan Yang, Dan Liu, Hui Xue, Panwen Tian, Lei Li · 2025 · PLoS ONE
21. Discovery and performance of DNA methylation panels for cancer detection and classification in blood
    Gennady Margolin, Sara R. Bang-Christensen, Sara A. Grimm, Brian D. Bennett, Peter Kilfeather, Kevin Fedkenheuer, Sabina Pathan, Nichelle C. Whitlock, Peter A. Pinto, Leszek J. Klimczak et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
22. Additional file 1 of Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer
    Alvida Qvick, Bianca Stenmark, Carlsson, Jessica, Johan Isaksson, Christina Karlsson, Gisela Helenius · 2021 · Figshare
23. Cell-free DNA analysis for cancer management: Technologies, features, and clinical translation
    Wei Zhu, Yan Mou, Lilan Yu, Kexin Fan, Kangnan Chen, Rufei Duan, Jianhong Ye, Sheng Huang, Jie Li, Ceshi Chen · 2026 · Molecular and Digital Medicine
24. Detection of Actionable Genomic Alterations beyond EGFR, ALK and ROS1 in Non-Small Cell Lung Carcinoma: A Real-World Evaluation of a Pathology-Led Staggered Reflex Predictive Biomarker Testing Strategy in a Resource-Limited Setting
    Aruna Nambirajan, Kaustar Yadav, Saumya Sahu, Snehvarsha Bhagat, Prajna Gopalakrishna, Shraddhanjali Satapathy, Warisa Khatoon, Suyash Devgan, Amita Singh, Aparna Sharma et al. · 2026 · Clinical Lung Cancer